 On Monday, August 10, Harrow Health NASDAQ: HROW will release its latest earnings report. Benzingas outlook for Harrow Health is included in the following report.Earnings and Revenue Based on managements projections, Harrow Health analysts modeled for EPS of -0.18 per share on sales of 5.70 million. In the same quarter last year, Harrow Health reported EPS of -0.09 on revenue of 13.52 million. If the company were to report in-line earnings when it publishes results Monday, earnings would be down 100.0. Sales would be down 51.57 from the year-ago period. Heres how the companys reported EPS has stacked up against analyst estimates in the past:Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019 EPS Estimate -0.25 0.05 -0.12 -0.07 EPS Actual -0.50 0.10 -0.26 -0.09 Revenue Estimate 11.77 M 13.66 M 12.85 M 12.78 M Revenue Actual 11.82 M 12.60 M 12.76 M 13.52 M Stock Performance Over the past 52-week period, shares of Harrow Health have declined 11.3. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.View more earnings on HROWDont be surprised to see the stock move on comments made during its conference call. Harrow Health is scheduled to hold the call at 17:00:00 ET and can be accessed here: more from Benzinga Earnings Preview: Infrastructure and Energy i3 Verticalss Earnings Outlook Earnings Outlook for Inovio PharmaceuticalsC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 